Behrooz Naghili
Overview
Explore the profile of Behrooz Naghili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahdi Khamaneh A, Jafari-Gharabaghlou D, Ansarin K, Pazooki P, Akbarpour Z, Naghili B, et al.
Oncol Rev
. 2025 Feb;
19:1516409.
PMID: 40017494
Breast cancer is the most prevalent neoplasm in women. ER (Luminal subtype), representing over 70% of breast tumors, is a genetically diverse group. Structural and Numerical-Chromosomal instability initiates tumor development...
2.
Mahdi Khamaneh A, Mohajeri N, Naghili B, Zarghami N
J Appl Genet
. 2024 Oct;
PMID: 39373948
Luminal A and B subtypes of breast tumors have fluctuated in proliferation rates, which arise from cell cycle dysregulation in cancer. Besides, microRNAs can regulate various cell processes through integration...
3.
Sheikhzadeh B, Rahbarnia L, Dehnad A, Naghili B, Saffarian P
Iran J Microbiol
. 2023 Jul;
15(3):408-413.
PMID: 37448680
Background And Objectives: Methicillin-resistant (MRSA) is one of the main causes of high mortality and morbidity in hospitals. This study was aimed to examine virulence factors, molecular typing, and the...
4.
Farajnia S, Lotfi F, Dehnad A, Shojaie M, Raisi R, Rahbarnia L, et al.
Iran J Microbiol
. 2023 May;
14(3):319-327.
PMID: 37124847
Background And Objectives: The objective of this study was to determine molecular characterization and genetic diversity of colistin-resistant clinical isolates in Intensive Care Unit hospitalized patients. Materials And Methods: A...
5.
Vaseghi N, Piramoon M, Khojasteh S, Abbasi K, Mohseni S, Javidnia J, et al.
Curr Med Mycol
. 2023 Jan;
8(2):8-15.
PMID: 36654787
Background And Purpose: Invasive candidiasis is a life-threatening condition that kills a large number of immunocompromised patients each year worldwide. We used post-antifungal effect studies to analyze the activities of...
6.
Akbarieh S, Naghili B, Valizade H, Beheshtirouy S, Sajedi B, Haramshahi M
Clin Case Rep
. 2022 Nov;
10(11):e6496.
PMID: 36381055
Mucormycosis is a group of life-threatening diseases caused by a fungus of the Mucoraceae family and has a higher mortality rate compared with other known fungal infections. Hydatid cyst, caused...
7.
Sadigh-Eteghad S, Shahi S, Mahmoudi J, Farjami A, Bazmani A, Naghili B, et al.
Curr Pharm Des
. 2022 Aug;
28(28):2330-2342.
PMID: 35909277
Infection of the central nervous system (CNS) is a global healthcare concern with high rates of death and disease. CNS infections mainly include meningitis, encephalitis, and brain abscesses. Bacteria, viruses,...
8.
Salatin S, Bazmani A, Shahi S, Naghili B, Memar M, Dizaj S
Curr Pharm Des
. 2022 May;
28(17):1419-1432.
PMID: 35579158
Nowadays, there is an urgent need to discover and develop long-term and effective antimicrobial and biofilm-inhibiting compounds. Employing combination therapies using novel drug delivery systems and also natural antimicrobial substances...
9.
Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, Rahbarnia L, Safary A, Zarredar H, et al.
Infection
. 2022 Mar;
50(4):1051.
PMID: 35237951
No abstract available.
10.
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, Rahbarnia L, Safary A, Zarredar H, et al.
Infection
. 2021 Jun;
49(6):1133-1147.
PMID: 34160789
The escalating prevalence of coronavirus disease 2019 (COVID-19) worldwide, with an increased rate of morbidity and mortality, highlights an urgent need to develop more effective therapeutic interventions. Despite the authorized...